Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    10648408 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty
Condition: Peripheral Arterial Disease
Interventions: Biological: G-CSF + CD133(+) cells;   Biological: G-CSF;   Procedure: percutaneous transluminal angioplasty (PTA);   Biological: Placebo infusion
2 Unknown  CD133+ Cell Therapy for Refractory Coronary Heart Disease
Condition: Coronary Artery Disease
Intervention: Procedure: Intracoronary Infusion of CD133+ Cells
3 Terminated A Prospective, Open, Non-randomized Phase I/II Study of Therapeutic Angiogenesis in Diabetic Patients With Critic Ischemia of Lower Limbs While Administering Positive CD133 Mobilized With G-CSF
Condition: Diabetic Patients With Critic Ischemia in Lower Limbs Who Are Administered With CD133+ Cells Mobilized by G-CSF
Intervention: Biological: CD133+ cells transplant

Study has passed its completion date and status has not been verified in more than two years.